A Message from the CEO

HuScience introduces a revolutionary paradigm in clinical trials through our advanced offerings. With the success of our Central Lab and Smart Trial Center, and leveraging cutting-edge ICT technology for Good Clinical Laboratory Practice, we are steadfastly evolving into the best global institute for clinical trials.

Founded in October 2021 through a strategic collaboration between Chung-Ang University and Dt&C, a KOSDAQ-listed entity, HuScience is a dynamic joint venture with a mission to revolutionize the realm of clinical trials. Our core offerings include specialized support for ‘Central Lab’ and ‘Smart Trial Center’ services.

In April 2022, our Central Lab proudly earned the esteemed designation as a Clinical Trial Sample Analysis Institution by the Ministry of Food and Drug Safety. As a pivotal component in the drug development process, and abiding by GCLP standards, we expertly handle clinical trial sample analysis, encompassing test method setup, lab kit production, and both domestic and international bio-logistics and data management.

Our dedication to advancing precision and innovation every step of the way can be seen in our Smart Trial Center, a groundbreaking initiative first introduced at Chung-Ang University Gwangmyeong Hospital. At HuScience, as we harness the power of AI, IoT, and blockchain technologies to automate clinical trial processes, we envision a future where our Central Lab and Smart Trial Center redefine the possibilities of clinical trials.

Our mission is to grow alongside our valued customers, constantly setting higher standards and achieving extraordinary results.

CEO Kwon Jo

Mission and Vision →